Literature DB >> 32016491

[Surgical treatment of hepatic tumors-liver resection and transplantation].

H Lang1, S Heinrich2, F Bartsch2, F Hüttl2, J Baumgart2, J Mittler2.   

Abstract

The most frequent primary hepatic malignancies are hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (intrahepatic cholangiocellular adenocarcinoma [iCCA]). For HCC in cirrhosis, liver transplantation offers the advantage of a complete hepatectomy radically removing all tumorous tissue along with the surrounding cirrhotic parenchyma, which is otherwise associated with a very high risk of recurrence. For HCC in non-cirrhotic livers and iCCA, liver resection is the treatment of choice. Nowadays, even extended resections can be performed with low mortality in experienced centers. Surgical therapy is more and more embedded into multimodal treatment concepts and decision making should be interdisciplinary as for other gastrointestinal tumors.

Entities:  

Keywords:  Carcinoma, hepatocellular; Cholangiocellular carcinoma, intrahepatic; Combined modality therapy; Liver cirrhosis; Technique of liver resection

Mesh:

Year:  2020        PMID: 32016491     DOI: 10.1007/s00108-020-00754-8

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  48 in total

1.  Prediction of postoperative outcome after hepatectomy with a new bedside test for maximal liver function capacity.

Authors:  Martin Stockmann; Johan F Lock; Björn Riecke; Karsten Heyne; Peter Martus; Michael Fricke; Sina Lehmann; Stefan M Niehues; Michael Schwabe; Arne-Jörn Lemke; Peter Neuhaus
Journal:  Ann Surg       Date:  2009-07       Impact factor: 12.969

2.  Assessment of the Lymph Node Status in Patients Undergoing Liver Resection for Intrahepatic Cholangiocarcinoma: the New Eighth Edition AJCC Staging System.

Authors:  Fabio Bagante; Gaya Spolverato; Matthew Weiss; Sorin Alexandrescu; Hugo P Marques; Luca Aldrighetti; Shishir K Maithel; Carlo Pulitano; Todd W Bauer; Feng Shen; George A Poultsides; Oliver Soubrane; Guillaume Martel; B Groot Koerkamp; Alfredo Guglielmi; Endo Itaru; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2017-04-19       Impact factor: 3.452

3.  Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma.

Authors:  John Bridgewater; Peter R Galle; Shahid A Khan; Josep M Llovet; Joong-Won Park; Tushar Patel; Timothy M Pawlik; Gregory J Gores
Journal:  J Hepatol       Date:  2014-03-27       Impact factor: 25.083

4.  Extended resection of intrahepatic cholangiocarcinoma: A retrospective single-center cohort study.

Authors:  Fabian Bartsch; Verena Tripke; Janine Baumgart; Maria Hoppe-Lotichius; Stefan Heinrich; Hauke Lang
Journal:  Int J Surg       Date:  2019-05-20       Impact factor: 6.071

5.  Perioperative and Long-Term Outcome for Intrahepatic Cholangiocarcinoma: Impact of Major Versus Minor Hepatectomy.

Authors:  Xu-Feng Zhang; Fabio Bagante; Jeffery Chakedis; Dimitrios Moris; Eliza W Beal; Matthew Weiss; Irinel Popescu; Hugo P Marques; Luca Aldrighetti; Shishir K Maithel; Carlo Pulitano; Todd W Bauer; Feng Shen; George A Poultsides; Oliver Soubrane; Guillaume Martel; B Groot Koerkamp; Alfredo Guglielmi; Endo Itaru; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2017-07-25       Impact factor: 3.452

6.  A novel vascular pattern promotes metastasis of hepatocellular carcinoma in an epithelial-mesenchymal transition-independent manner.

Authors:  Jian-Hong Fang; Hui-Chao Zhou; Chong Zhang; Li-Ru Shang; Lei Zhang; Jing Xu; Limin Zheng; Yunfei Yuan; Rong-Ping Guo; Wei-Hua Jia; Jing-Ping Yun; Min-Shan Chen; Yaojun Zhang; Shi-Mei Zhuang
Journal:  Hepatology       Date:  2015-04-22       Impact factor: 17.425

7.  Liver transplantation for hepatocellular carcinoma: a model including α-fetoprotein improves the performance of Milan criteria.

Authors:  Christophe Duvoux; Françoise Roudot-Thoraval; Thomas Decaens; Fabienne Pessione; Hanaa Badran; Tullio Piardi; Claire Francoz; Philippe Compagnon; Claire Vanlemmens; Jérome Dumortier; Sébastien Dharancy; Jean Gugenheim; Pierre-Henri Bernard; René Adam; Sylvie Radenne; Fabrice Muscari; Filomena Conti; Jean Hardwigsen; Georges-Philippe Pageaux; Olivier Chazouillères; Ephrem Salame; Marie-Noelle Hilleret; Pascal Lebray; Armand Abergel; Marilyne Debette-Gratien; Michael D Kluger; Ariane Mallat; Daniel Azoulay; Daniel Cherqui
Journal:  Gastroenterology       Date:  2012-06-29       Impact factor: 22.682

Review 8.  Intrahepatic cholangiocarcinoma: macroscopic type and stage classification.

Authors:  Susumu Yamasaki
Journal:  J Hepatobiliary Pancreat Surg       Date:  2003

9.  Operations for intrahepatic cholangiocarcinoma: single-institution experience of 158 patients.

Authors:  Hauke Lang; Georgios C Sotiropoulos; George Sgourakis; Klaus J Schmitz; Andreas Paul; Philip Hilgard; Thomas Zöpf; Tanja Trarbach; Massimo Malagó; Hideo A Baba; Christoph E Broelsch
Journal:  J Am Coll Surg       Date:  2009-02       Impact factor: 6.113

Review 10.  Fibrolamellar hepatocellular carcinoma: current clinical perspectives.

Authors:  Kelly J Lafaro; Timothy M Pawlik
Journal:  J Hepatocell Carcinoma       Date:  2015-10-09
View more
  4 in total

1.  Alpha-fetoprotein level to total tumor volume as a predictor of hepatocellular carcinoma recurrence after resection. A retrospective cohort study.

Authors:  Hazem M Zakaria; Anwar Mohamed; Hazem Omar; Nahla K Gaballa
Journal:  Ann Med Surg (Lond)       Date:  2020-05-04

2.  Total tumor volume as a prognostic value for survival following liver resection in patients with hepatocellular carcinoma. Retrospective cohort study.

Authors:  Hazem M Zakaria; Mahmoud Macshut; Nahla K Gaballa; Ahmed E Sherif; Mohammed E Abdel-Samea; Mohamed Abdel-Samiee; Ibrahim Marwan; Taha Yassein
Journal:  Ann Med Surg (Lond)       Date:  2020-04-07

3.  Identification of G6PC as a potential prognostic biomarker in hepatocellular carcinoma based on bioinformatics analysis.

Authors:  Li Tian; Yong Liao
Journal:  Medicine (Baltimore)       Date:  2022-08-19       Impact factor: 1.817

4.  Asiaticoside Antagonizes Proliferation and Chemotherapeutic Drug Resistance in Hepatocellular Carcinoma (HCC) Cells.

Authors:  Ying Ma; Jun Wen; Jing Wang; Chunyan Wang; Yan Zhang; Lili Zhao; Jia Li; Xue Feng
Journal:  Med Sci Monit       Date:  2020-08-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.